The earnings call highlighted strong cash flow management and sustainability progress. However, these positives were overshadowed by significant challenges in market growth, especially in the U.S., declining ASP and gross margins, and the lack of organic growth. The acquisition of KIND Group is a positive strategic move but was offset by the immediate operational and market challenges.
Company Guidance
During the conference call, Demant provided guidance that highlighted a challenging environment for the global hearing aid market, which grew below the typical 4% to 6% expectation due to macroeconomic uncertainties. The company's first-half 2025 performance showed 0% organic growth, influenced by a decline in the global average selling price (ASP) and lower sales in the U.S. market. Demant reported a gross margin decline of 0.8 percentage points and an EBIT before special items of DKK 1.849 billion, with a contraction in EBIT margin due to unfavorable geographic and product mix changes. The company adjusted its outlook for the global hearing aid market to 1% to 3% growth in value and revised its EBIT forecast to EUR 3.9 billion to EUR 4.3 billion. Despite these challenges, Demant achieved a solid cash flow from operations of over DKK 1.5 billion. Sustainability efforts included a 5% reduction in Scope 1 and 2 greenhouse gas emissions and a 94% training rate in the company's code of conduct. The company's strategic acquisition of the KIND Group was also noted, with share buyback paused following this agreement.
Strong Cash Flow Performance
Delivered solid cash flow from operations of over DKK 1.5 billion and free cash flow of DKK 1.126 billion, which demonstrates strong cash management despite lower profitability.
Sustainability Progress
Decreased Scope 1 and 2 market-based greenhouse gas emissions by 5% by increasing the share of renewable electricity, achieving 94% training of highly exposed employees in Demant's code of conduct.
Acquisition of KIND Group
Agreed to acquire the KIND Group, a leading retailer of hearing aids with around 650 clinics primarily in Germany, marking a significant expansion in retail operations.
Demant (WILYY) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
WILYY Earnings-Related Price Changes
Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Aug 12, 2025
$19.67
$19.79
+0.61%
Feb 05, 2025
$19.64
$18.40
-6.31%
Aug 14, 2024
$19.28
$19.67
+2.02%
Feb 05, 2024
$23.07
$22.95
-0.52%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Demant (WILYY) report earnings?
Demant (WILYY) is schdueled to report earning on Feb 10, 2026, TBA (Confirmed).
What is Demant (WILYY) earnings time?
Demant (WILYY) earnings time is at Feb 10, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.